Abstract:The activation of glial cells is intimately associated with the pathophysiology of neuroinflammation and white matter injury (WMI) during both acute and chronic phases following subarachnoid hemorrhage (SAH). The complement C3a receptor (C3aR) has a dual role in modulating inflammation and contributes to neurodevelopment, neuroplasticity, and neurodegeneration. However, its impact on WMI in the context of SAH remains unclear. In this study, 175 male C57BL/6J mice underwent SAH through endovascular perforation. Oxyhemoglobin (oxy-Hb) was employed to simulate SAH in vitro. A suite of techniques, including immunohistochemistry, transcriptomic sequencing, and a range of molecular biotechnologies, were utilized to evaluate the activation of the C3-C3aR pathway on microglial polarization and WMI. Results revealed that post-SAH abnormal activation of microglia was accompanied by upregulation of complement C3 and C3aR. The inhibition of C3aR decreased abnormal microglial activation, attenuated neuroinflammation, and ameliorated WMI and cognitive deficits following SAH. RNA-Seq indicated that C3aR inhibition downregulated several immune and inflammatory pathways and mitigated cellular injury by reducing p53-induced death domain protein 1 (Pidd1) and Protein kinase RNA-like ER kinase (Perk) expression, two factors mainly function in sensing and responding to cellular stress and endoplasmic reticulum (ER) stress. The deleterious effects of the C3-C3aR axis in the context of SAH may be related to endoplasmic reticulum (ER) stress-dependent cellular injury and inflammasome formation. Agonists of Perk can exacerbate the cellular injury and neuroinflammation, which was attenuated by C3aR inhibition after SAH. Additionally, intranasal administration of C3a during the subacute phase of SAH was found to decrease astrocyte reactivity and alleviate cognitive deficits post-SAH. This research deepens our understanding of the complex pathophysiology of WMI following SAH and underscores the therapeutic potential of C3a treatment in promoting white matter repair and enhancing functional recovery prognosis. These insights pave the way for future clinical application of C3a-based therapies, promising significant benefits in the treatment of SAH and its related complications.

Ldl-stimulated microglial activation exacerbates ischemic white matter damage

Microglia exacerbate white matter injury via complement C3/C3aR pathway after hypoperfusion

Impaired Meningeal Lymphatics and Glymphatic Pathway in Patients with White Matter Hyperintensity

Microglial Activation with Reduction in Autophagy Limits White Matter Lesions and Improves Cognitive Defects During Cerebral Hypoperfusion

M1-type microglia-derived exosomes contribute to blood–brain barrier damage

Hippo/MST1 Signaling Mediates Microglial Activation Following Acute Cerebral Ischemia–reperfusion Injury

Microglial Hv1 Proton Channels Promote White Matter Injuries after Chronic Hypoperfusion in Mice.

Aberrant oligodendroglial LDL receptor orchestrates demyelination in chronic cerebral ischemia

Dynamic Brain Lipid Profiles Modulate Microglial Lipid Droplet Accumulation and Inflammation Under Ischemic Conditions in Mice

Microglial TLR4 Mediates White Matter Injury in a Combined Model of Diesel Exhaust Exposure and Cerebral Hypoperfusion

Microglia LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8+ T cell recruitment

Perioperative stroke deteriorates white matter integrity by enhancing cytotoxic CD8+ T-cell activation

Microglia aggravate white matter injury via C3/C3aR pathway after experimental subarachnoid hemorrhage

Pharmacological Upregulation of Microglial Lipid Droplet Alleviates Neuroinflammation and Acute Ischemic Brain Injury

Hypoxic postconditioning drives protective microglial responses and ameliorates white matter injury after ischemic stroke

Microglia Regulate Blood–Brain Barrier Integrity via MiR‐126a‐5p/MMP9 Axis during Inflammatory Demyelination

CD36 deletion prevents white matter injury by modulating microglia polarization through the Traf5-MAPK signal pathway

Cx3cl1/Cx3cr1-Mediated Microglia Activation Plays A Detrimental Role in Ischemic Mice Brain Via P38mapk/Pkc Pathway

Long-term Microglial Phase-specific Dynamics During Single Vessel Occlusion and Recanalization

Abstract WP104: Neuron- Microglia Crosstalk Mediated by Soluble Fas Ligand after Ischemic Stroke

Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter